These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

789 related articles for article (PubMed ID: 17323403)

  • 41. Sociodemographic factors influence use of proton pump inhibitors among users of nonsteroidal anti-inflammatory drugs.
    van Boxel OS; Hagenaars MP; Smout AJ; Siersema PD
    Clin Gastroenterol Hepatol; 2009 Aug; 7(8):855-61. PubMed ID: 19465157
    [TBL] [Abstract][Full Text] [Related]  

  • 42. NSAID-induced gastrointestinal damage: current clinical management and recommendations for prevention.
    Lanas A; Ferrandez A
    Chin J Dig Dis; 2006; 7(3):127-33. PubMed ID: 16808792
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non-steroidal anti-inflammatory drugs.
    van der Linden MW; van der Bij S; Welsing P; Kuipers EJ; Herings RM
    Ann Rheum Dis; 2009 May; 68(5):668-73. PubMed ID: 18495734
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A pharmacoeconomic comparison of misoprostol/diclofenac with diclofenac.
    Morant SV; Shield MJ; Davey PG; MacDonald TM
    Pharmacoepidemiol Drug Saf; 2002; 11(5):393-400. PubMed ID: 12271881
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adherence to gastroprotection and the risk of NSAID-related upper gastrointestinal ulcers and haemorrhage.
    van Soest EM; Sturkenboom MC; Dieleman JP; Verhamme KM; Siersema PD; Kuipers EJ
    Aliment Pharmacol Ther; 2007 Jul; 26(2):265-75. PubMed ID: 17593072
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Factors affecting efficacy of proton pump inhibitors in NAID-induced gastric ulcers].
    Karateev AE; Diukov IV
    Ter Arkh; 2007; 79(5):54-9. PubMed ID: 17672076
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gastroprotective drugs in Australia: utilization patterns between 1997 and 2006 in relation to NSAID prescribing.
    Barozzi N; Tett SE
    Clin Ther; 2009 Apr; 31(4):849-61. PubMed ID: 19446158
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Trends and determinants of adequate gastroprotection in patients chronically using NSAIDs.
    Helsper CW; Smeets HM; Numans ME; Knol MJ; Hoes AW; de Wit NJ
    Pharmacoepidemiol Drug Saf; 2009 Sep; 18(9):800-6. PubMed ID: 19572313
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease.
    Shorr RI; Ray WA; Daugherty JR; Griffin MR
    Arch Intern Med; 1993 Jul; 153(14):1665-70. PubMed ID: 8333804
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Outcome of peptic ulcer bleeding among users of traditional non-steroidal anti-inflammatory drugs and selective cyclo-oxygenase-2 inhibitors.
    Thomsen RW; Riis A; Christensen S; McLaughlin JK; Sørensen HT
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1431-8. PubMed ID: 17032286
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Utilization of non-steroidal anti-inflammatory drugs in Quebec: adherence to the Canadian consensus on prescription guidelines.
    Moride Y; Ducruet T; Boivin JF; Lavoie F; Rochon S
    Can J Clin Pharmacol; 2005; 12(2):e201-11. PubMed ID: 15998959
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of gastroprotection in patients discharged from hospital on nonsteroidal anti-inflammatory drugs.
    Coté GA; Norvell JP; Rice JP; Bulsiewicz WJ; Howden CW
    Am J Ther; 2008; 15(5):444-9. PubMed ID: 18806520
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Underutilization of gastroprotective measures in patients receiving nonsteroidal antiinflammatory drugs.
    Smalley W; Stein CM; Arbogast PG; Eisen G; Ray WA; Griffin M
    Arthritis Rheum; 2002 Aug; 46(8):2195-200. PubMed ID: 12209525
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Analysis of differences between indication and prescription of gastroprotection in patients with risk factors treated with nonsteroidal anti-inflammatory agents: the GAP study].
    Lanas A; Muñoz M; Caballero Correa M; Martínez Jiménez P;
    Gastroenterol Hepatol; 2010 Feb; 33(2):80-91. PubMed ID: 19931944
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Colorectal neoplasia in veterans is associated with Barrett's esophagus but not with proton-pump inhibitor or aspirin/NSAID use.
    Siersema PD; Yu S; Sahbaie P; Steyerberg EW; Simpson PW; Kuipers EJ; Triadafilopoulos G
    Gastrointest Endosc; 2006 Apr; 63(4):581-6. PubMed ID: 16564855
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nonsteroidal anti-inflammatory drugs, aspirin, and gastrointestinal prophylaxis: an ounce of prevention.
    Scheiman JM
    Rev Gastroenterol Disord; 2005; 5 Suppl 2():39-49. PubMed ID: 16369226
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs.
    Eurich DT; Sadowski CA; Simpson SH; Marrie TJ; Majumdar SR
    Am J Med; 2010 Jan; 123(1):47-53. PubMed ID: 20102991
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Underutilization of gastroprotective strategies in aspirin users at increased risk of upper gastrointestinal complications.
    Targownik LE; Metge CJ; Leung S
    Aliment Pharmacol Ther; 2008 Jul; 28(1):88-96. PubMed ID: 18410563
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevention of anti-inflammatory drug-induced gastrointestinal damage: benefits and risks of therapeutic strategies.
    Lanas A; Hunt R
    Ann Med; 2006; 38(6):415-28. PubMed ID: 17008305
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevention of gastroduodenal damage with omeprazole in patients receiving continuous NSAIDs treatment. A double blind placebo controlled study.
    Bianchi Porro G; Lazzaroni M; Petrillo M; Manzionna G; Montrone F; Caruso I
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):43-7. PubMed ID: 9615264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.